Amit Sachdev Insider Trading for February 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Amit Sachdev.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of Amit Sachdev for February 2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26 2021 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 216.62 | 200 | 43,324 | 40,133 | 40.3 K to 40.1 K (-0.50 %) |
| Feb 26 2021 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 215.56 | 336 | 72,428 | 40,333 | 40.7 K to 40.3 K (-0.83 %) |
| Feb 26 2021 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 214.19 | 668 | 143,079 | 40,669 | 41.3 K to 40.7 K (-1.62 %) |
| Feb 26 2021 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 213.30 | 1,460 | 311,418 | 41,337 | 42.8 K to 41.3 K (-3.41 %) |
| Feb 26 2021 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 211.56 | 922 | 195,058 | 42,797 | 43.7 K to 42.8 K (-2.11 %) |
| Feb 26 2021 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Payment of Exercise | F | 217.57 | 2,946 | 640,961 | 43,719 | 46.7 K to 43.7 K (-6.31 %) |
| Feb 19 2021 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 213.02 | 800 | 170,416 | 46,665 | 47.5 K to 46.7 K (-1.69 %) |
| Feb 19 2021 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 212.15 | 5,800 | 1,230,470 | 47,465 | 53.3 K to 47.5 K (-10.89 %) |
| Feb 19 2021 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 211.36 | 1,500 | 317,040 | 53,265 | 54.8 K to 53.3 K (-2.74 %) |
| Feb 19 2021 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 210.00 | 1,164 | 244,440 | 54,765 | 55.9 K to 54.8 K (-2.08 %) |
| Feb 19 2021 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Payment of Exercise | F | 211.75 | 7,613 | 1,612,053 | 55,929 | 63.5 K to 55.9 K (-11.98 %) |
| Feb 12 2021 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Payment of Exercise | F | 214.16 | 2,421 | 518,481 | 68,002 | 70.4 K to 68 K (-3.44 %) |
| Feb 05 2021 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Grant | A | 0.00 | 11,627 | 0 | 70,423 | 58.8 K to 70.4 K (+19.78 %) |
| Feb 05 2021 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Grant | A | 0.00 | 10,324 | 0 | 58,796 | 48.5 K to 58.8 K (+21.30 %) |
| Feb 05 2021 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Grant | A | 0.00 | 10,126 | 0 | 48,472 | 38.3 K to 48.5 K (+26.41 %) |
| Feb 05 2021 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Gift | G | 0.00 | 3,391 | 0 | 7,368 | 10.8 K to 7.4 K (-31.52 %) |
| Feb 05 2021 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Grant | A | 0.00 | 11,627 | 0 | 70,423 | 58.8 K to 70.4 K (+19.78 %) |
| Feb 05 2021 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Grant | A | 0.00 | 10,324 | 0 | 58,796 | 48.5 K to 58.8 K (+21.30 %) |
| Feb 05 2021 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Grant | A | 0.00 | 10,126 | 0 | 48,472 | 38.3 K to 48.5 K (+26.41 %) |
| Feb 05 2021 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Gift | G | 0.00 | 3,391 | 0 | 7,368 | 10.8 K to 7.4 K (-31.52 %) |